ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 688526 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 688526; 2) Community: the network communities that were significantly associated with the response to NSC 688526; 3) Molecule: the relationships between components within communities and NSC 688526; 4) MDR: the compounds that were significantly associated with the NSC 688526.

NSC Compound Enrichment Correlation
NSC 740 Methotrexate 0.00356914129105571 -0.33106079
NSC 753769 Null 0.00356914129105571 0.58813812
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.00356914129105571 -0.39864514
NSC 179187 Salasdine 0.00356914129105573 0.47880885
NSC 35489 Null 0.00356914129105573 -0.31450702
NSC 631477 p-Chloranilinum[bis(p-chloraniline)dioxalatoruthenate(III)] 0.00356914129105573 -0.21235623
NSC 638038 Null 0.00356914129105573 -0.23905463
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.00356914129105573 -0.084709037
NSC 660032 Null 0.00356914129105573 0.55074948
NSC 661940 2-(2-chloroethoxy)naphthazarin 0.00356914129105573 -0.32423313
Total:92  Current:11    [First] [Prev] [Next] [Last]